Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

Authors: Pepper, Andrea G. S., Zucchetto, Antonella, Norris, Kevin, Tissino, Erika, Polesel, Jerry, Soe, Zarni, Allsup, David, Hockaday, Anna, Ow, Pei Loo, Hillmen, Peter, Rawstron, Andrew, Catovsky, Daniel, Bulian, Pietro, Bomben, Riccardo, Baird, Duncan M., Fegan, Christopher D., Gattei, Valter, Pepper, Chris

Source: Leukemia. 36(1):271-274

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100193143379.0x000001&indx=1&recIds=ETOCvdc_100193143379.0x000001

Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length

Authors: Boyle, Eileen M., Williams, Louis, Blaney, Patrick, Ashby, Cody, Bauer, Michael, Walker, Brian A., Ghamlouch, Hussein, Choi, Jinyoung, Perrial, Emeline, Wang, Yubao, Caro, Jessica, Stoeckle, James H., Arbini, Arnaldo, Kaminetzky, David, Braunstein, Marc, Bruno, Benedetto, Razzo, Beatrice, Diamond, Benjamin, Maclachlan, Kylee, Maura, Francesco, Landgren, Ola, Litke, Rachel, Fegan, Christopher D., Keats, Johnathan, Auclair, Daniel, Davies, Faith E., Morgan, Gareth J.

Source: Leukemia. 36(1):221-224

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100193143361.0x000001&indx=1&recIds=ETOCvdc_100193143361.0x000001

TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target

Authors: Kennedy, Emma ^*, Coulter, Eve ^*, Halliwell, Emma, Profitos-Peleja, Nuria, Walsby, Elisabeth, Clark, Barnaby, Phillips, Elizabeth H., Burley, Thomas A., Mitchell, Simon, Devereux, Stephen, Fegan, Christopher D., Jones, Christopher I., Johnston, Rosalynd, Chevassut, Tim, Schulz, Ralph, Seiffert, Martina, Agathanggelou, Angelo, Oldreive, Ceri, Davies, Nicholas, Stankovic, Tatjana, Liloglou, Triantafillos, Pepper, Chris, Pepper, Andrea G.S. ^*

Source: In Blood 3 June 2021 137(22):3064-3078

Single Use Disposable Equipment Is Not Being Used Everywhere

Authors: Min, Sandra Young, Aleem, Aamer, Al-Obaidi, Magda Jabbar, Justice, Elizabeth, Fegan, Christopher D.

Source: BMJ: British Medical Journal, 2001 May . 322(7297), 1307-1307.

Access URL: https://www.jstor.org/stable/25467020

Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses

Authors: Milligan, Donald W., Fernandes, Savio, Dasgupta, Ranjit, Davies, Faith E., Matutes, Estella, Fegan, Christopher D., McConkey, Christopher, Child, J. Anthony, Cunningham, David, Morgan, Gareth J., Catovsky, Daniel

Source: In Blood 1 January 2005 105(1):397-404

The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia

Authors: Cook, Mark A. ^*, Milligan, Donald W., Fegan, Christopher D., Darbyshire, Philip J., Mahendra, Premini, Craddock, Charles F., Moss, Paul A.H., Briggs, David C.

Source: In Blood 15 February 2004 103(4):1521-1526

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

Authors: Avivi, Irit, Chakrabarti, Suparno ^*, Milligan, Donald W, Waldmann, H, Hale, Geoff, Osman, Husam, Ward, Katherine N, Fegan, Christopher D, Yong, Kwee, Goldstone, Anthony H, Linch, David C, MacKinnon, Stephen

Source: In Biology of Blood and Marrow Transplantation 2004 10(3):186-194

Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin

Authors: Lim, Albert Y.H, Parr, David G, Stableforth, David E, Fellows, Melanie, Fontaine, Robin, Fegan, Christopher D ^∗

Source: In European Journal of Internal Medicine 2003 14(2):89-93

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Authors: Chakrabarti, Suparno, Mackinnon, Stephen, Chopra, Raj, Kottaridis, Panagiotis D., Peggs, Karl, O'Gorman, Peter, Chakraverty, Ronjon, Marshall, Timothy, Osman, Husam, Mahendra, Premini, Craddock, Charles, Waldmann, Herman, Hale, Geoff, Fegan, Christopher D., Yong, Kwee, Goldstone, Anthony H., Linch, David C., Milligan, Donald W.

Source: In Blood 15 June 2002 99(12):4357-4363

Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia

Authors: Auer, Rebecca L., Jones, Christopher, Mullenbach, Roman A., Syndercombe-Court, Denise, Milligan, Donald W., Fegan, Christopher D., Cotter, Finbarr E.

Source: In Blood 15 January 2001 97(2):509-515

Telomere length predicts for outcome to FCR chemotherapy in CLL

Authors: Norris, Kevin, Hillmen, Peter, Rawstron, Andrew, Hills, Robert, Baird, Duncan M., Fegan, Christopher D., Pepper, Chris

Source: Leukemia; August 2019, Vol. 33 Issue: 8 p1953-1963, 11p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Reconstitution of the Epstein-Barr virus–specific cytotoxic T-lymphocyte response following T-cell–depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation

Authors: Chakrabarti, Suparno, Milligan, Donald W., Pillay, Deenan, Mackinnon, Stephen, Holder, Kathleen, Kaur, Narinder, McDonald, Dorothy, Fegan, Christopher D., Waldmann, Herman, Hale, Geoff, Rickinson, Alan, Steven, Neil ^*

Source: In Blood 1 August 2003 102(3):839-842

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality.

Authors: Chakrabarti, Suparno, Avivi, Irit, Mackinnon, Stephen, Ward, Kate, Kottaridis, Panagiotis D., Osman, Husam, Waldmann, H., Hale, Geoff, Fegan, Christopher D., Yong, Kwee, Goldstone, Anthony H., Linch, David C., Milligan, Donald W.

Source: British Journal of Haematology; Dec2002, Vol. 119 Issue 4, p1125-1132, 8p

Subject Terms: RESPIRATORY infections, VIRUS diseases

The impact of donor KIRand patient HLA-Cgenotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia

Authors: Cook, Mark A., Milligan, Donald W., Fegan, Christopher D., Darbyshire, Philip J., Mahendra, Premini, Craddock, Charles F., Moss, Paul A.H., Briggs, David C.

Source: Blood; February 2004, Vol. 103 Issue: 4 p1521-1526, 6p

RESPIRATORY VIRUS INFECTIONS IN ADULT T CELL-DEPLETED TRANSPLANT RECIPIENTS THE ROLE OF CELLULAR IMMUNITY

Authors: Chakrabarti, Suparno, Collingham, Kathryn E., Marshall, Timothy, Holder, Kathleen, Gentle, Trudy, Hale, Geoff, Fegan, Christopher D., Milligan, Donald W.

Source: Transplantation; October 2001, Vol. 72 Issue: 8 p1460-1463, 4p

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Authors: Cotter, Finbarr E. ^*, Su, Bo ^*, Corbo, Margherita ^*, Chang, Y. ^*, Schindler, Joanne ^*, Carver, Brad ^*, Fegan, Christopher D. ^*, Newland, Adrian C., Auer, Rebecca L. ^*

Source: In Blood 16 November 2004 104(11):3286-3286